Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008373
Filing Date
2017-05-03
Accepted
2017-05-03 16:13:41
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20170331.htm 10-Q 1658942
2 EX-31.1 arwr-ex311_8.htm EX-31.1 10858
3 EX-31.2 arwr-ex312_7.htm EX-31.2 11272
4 EX-32.1 arwr-ex321_9.htm EX-32.1 6694
5 EX-32.2 arwr-ex322_6.htm EX-32.2 6912
  Complete submission text file 0001564590-17-008373.txt   5336174

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20170331.xml EX-101.INS 807424
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20170331.xsd EX-101.SCH 42681
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20170331_cal.xml EX-101.CAL 48539
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20170331_def.xml EX-101.DEF 176613
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20170331_lab.xml EX-101.LAB 391795
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20170331_pre.xml EX-101.PRE 315117
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 17809329
SIC: 2834 Pharmaceutical Preparations